Astellas Pharma buying Universal Cells for $102M in Seattle’s third biotech acquisition in a month by Clare McGrane on February 15, 2018February 15, 2018 at 9:53 am Astellas Pharma, a Japanese pharmaceutical and biotechnology company, is acquiring Seattle biotech Universal Cells. Astellas will pay up to $102.5 million for Universal Cells inĀ upfront and milestone payments, assuming the… Read More